Novel Benchmark Scaling Method for First-in-Human Dose of CAR-T Therapies

被引：0
|
作者：
Zhu, Xu [1 ]
Stein, Andrew [1 ]
Pearson, David [2 ]
Price, Andrew [1 ]
Sohoni, Akash [1 ]
Barton, Nathaniel [1 ]
Bradshaw, Laura [1 ]
Pinzon-Ortiz, Maria [1 ]
Bu, Dexiu [1 ]
Engels, Boris [1 ]
机构：
[1] Novartis Inst Biomed Res, Cambridge, MA USA
[2] Novartis Pharma AG, Basel, Switzerland
来源：
MOLECULAR THERAPY | 2022年 / 30卷 / 04期
关键词：
D O I：
暂无
中图分类号：
Q81 [生物工程学（生物技术）]; Q93 [微生物学];
学科分类号：
071005 ; 0836 ; 090102 ; 100705 ;
摘要：
1124
引用
收藏
页码：524 / 524
页数：1
相关论文
共 50 条
  • [31] Developing CAR-T cells therapies : Is the European law adequate ?
    Pichereau, D.
    Chabannon, C.
    Rial-Sebbag, E.
    EUROPEAN JOURNAL OF HUMAN GENETICS, 2019, 27 : 605 - 606
  • [32] Review of CAR-T therapies' reports to the pharmacovigilance centre of Cantabria
    Marana, I. Mazon
    Cuellar Gomez, D. Z.
    Gonzalez Ruiz, M.
    Sanchez Escamilla, M.
    Cerezo Martin, J. M.
    Cadenas Mancenido, A.
    Garcia Saiz, M.
    BASIC & CLINICAL PHARMACOLOGY & TOXICOLOGY, 2024, 135 : 35 - 35
  • [33] CAR-T cell therapies targeting aspartyl β-hydroxylase (ASPH)
    Thisted, Thomas
    Malhotra, Kanam
    Lebowitz, Michael S.
    Ghanbari, Hossein
    CANCER RESEARCH, 2019, 79 (13)
  • [34] CHARACTERIZING EVIDENTIARY CRITERIA IN HTA ASSESSMENTS OF CAR-T THERAPIES
    OBrien, M.
    Fernandez, P.
    Freilich, J.
    Thorel, A.
    Chawla, A.
    VALUE IN HEALTH, 2022, 25 (07) : S510 - S510
  • [35] Primary Bone Tumors: Challenges and Opportunities for CAR-T Therapies
    Folkert, Ian W.
    Devalaraja, Samir
    Linette, Gerald P.
    Weber, Kristy
    Haldar, Malay
    JOURNAL OF BONE AND MINERAL RESEARCH, 2019, 34 (10) : 1780 - 1788
  • [36] Investigating metabolic basis of neurotoxicity during CAR-T therapies
    Salloum, Darin
    Santomasso, Bianca
    Brentjens, Renier J.
    Wendel, Hans-Guido
    CANCER IMMUNOLOGY RESEARCH, 2019, 7 (02)
  • [37] Restricted Access to CAR-T Cell Therapies due to Uncertainty
    不详
    PHARMACEUTICAL MEDICINE, 2020, 34 (01) : 68 - 69
  • [38] COMMUNITY ONCOLOGISTS' PERCEPTION AND ADAPTABILITY TO EMERGING CAR-T THERAPIES
    Nabhan, C.
    Feinberg, B. A.
    Ernst, F. R.
    Fillman, J.
    VALUE IN HEALTH, 2017, 20 (05) : A137 - A137
  • [39] Chemotherapy resistant Burkitt lymphoma: Possible novel therapies including CAR-T cell infusion
    Geerts, Paulus A. F.
    Hart, Nils't
    Visser, Otto
    Ortiz-Maldonado, Valentin
    Chamuleau, Martine E. D.
    CLINICAL CASE REPORTS, 2023, 11 (06):
  • [40] A NOVEL MANUFACTURING PROCESS FOR CAR-T CELL THERAPIES IN AN AUTOMATED STIRRED-TANK BIOREACTOR
    Costariol, E.
    Rafiq, Q. A.
    CYTOTHERAPY, 2019, 21 (05) : S34 - S35
12345